4 SMID-Cap Biotechs Barclays Just Confessed It Loves
May 21, 2015 at 09:00 AM EDT
In a new research note, Barclays analysts said that the run in biotech stocks is not over. In fact, the firm initiated coverage on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.